Author: Jack Florin

Searching for Therapies for Progressive MS

There are now 11 medications, FDA approved, for relapsing and remitting MS. Other than Novantrone, which is no longer used because of safety issues that were worse than initially predicted, no medication has been approved for progressive MS. The current thrust of research is neuroprotection rather than anti-inflammatory effects. Below is the summary of studies… Read more »

Parkinson’s and a Diabetic Drug

Coffee has been consistently shown when drunk in large amounts to reduce the risk of developing Parkinson’s. Also, patients who smoke cigarettes have a lower risk of Parkinson’s. It has been hard to understand why this should be so, but recent studies point to the fact that Parkinson’s disease patients, because they have less dopamine… Read more »

A new way to treat off-periods in Parkinson’s – Inhaled Levodopa

This device is in clinical trials but seems likely to be approved by the FDA and may be available in 1 to 2 years. The therapy is called CVT-301. It is inhaled as one would use an asthma inhaler. Patients with long-standing Parkinson’s almost always develop motor fluctuations, also called on-off effects. Manipulating the levodopa… Read more »